USPTO serial 79045184
SYNHUMANISATION
Reviewed by CopyMark Law Group
Reg. 3512766Status 404
- Filing date
- Status date
- Registration date
- Oct 7, 2008
- Examiner
- BLANE, SUZANNE
- Law office
- TMO LAW OFFICE 114
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SYNHUMANISATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Arana Therapeutics Limited ACN No. 002 951 877
AU
Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
Arana Therapeutics Limited ACN No. 002 951 877
AU
Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
Arana Therapeutics Limited ACN No. 002 951 877
AU
Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
N. Christopher Norton
N. Christopher Norton, Esq. ARENT FOX LLP1717 K Street, N.W.WASHINGTON, DC 20036-5342UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical substances and preparations, namely, antibodies, antibody reagents, antibody derivatives and antibody fragments for scientific and research purposes | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, medical, veterinary and sanitary preparations, namely, antibodies, antibody reagents, antibody derivatives and antibody fragments for therapeutic use in humans and animals, namely, in the treatment of autoimmune diseases, inflammatory diseases, bone diseases, infectious diseases, cardiovascular diseases, ocular conditions and cancer; diagnostic preparations and reagents for medical use; diagnostic test kits consisting of diagnostic preparations and reagents for medical use | SECTION 71 - CANCELLED | — |
| 040 | Custom assembly for others of medical goods made to the order and specification of others; custom assembly for others of pharmaceutical products; chemical processing and transformation for others of organic substances, namely, combining antibody sequences to develop antibodies suitable for use in humans | SECTION 71 - CANCELLED | — |
| 042 | Research and development services in the field of antibody product development; medical, surgical, veterinary, scientific and industrial research and development services relating to antibody product development; developing antibodies, antibody derivatives and antibody fragments for therapeutic use in humans and animals, namely, in the treatment of autoimmune diseases, inflammatory diseases, bone diseases, infectious diseases, cardiovascular diseases, ocular conditions and cancer; advisory and consultancy services relating to antibody products; custom design of medical goods made to the order and specification of others | SECTION 71 - CANCELLED | — |
| 044 | Medical and veterinary services; medical, pharmacy and veterinary advice and consultancy services | SECTION 71 - CANCELLED | — |
| 045 | Licensing of intellectual property; management of intellectual property | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
- Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
- Other trademarks owned by Arana Therapeutics Limited ACN No. 002 951 877
- Other trademarks owned by Peptech Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named SYNHUMANISATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 25, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 17, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 11, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 11, 2016 | INPC | INVALIDATION PROCESSED | — |
| Jan 8, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 8, 2015 | C71T | CANCELLED SECTION 71 | — |
| Jan 21, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 6, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 26, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 26, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 8, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 7, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 22, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 28, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 14, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 13, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| May 27, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 27, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 27, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2008 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2008 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 14, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 27, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 27, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 27, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 26, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 15, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |